Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

BackgroundThe use of Direct Oral Anticoagulants (DOACs) in patients who have both atrial fibrillation (AF) and end-stage renal disease (ESRD) requiring hemodialysis remains controversial, with warfarin remaining the mainstay of the treatment. As hemodialysis patients were excluded from most clinical...

Full description

Bibliographic Details
Main Authors: Sohil Elfar, Sara Mohamed Elzeiny, Hesham Ismail, Yahya Makkeyah, Mokhtar Ibrahim
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
hemodialysis
anticoagulants
atrial fibrillation
novel anticoagulation
renal failure
direct anticoagulant
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.847286/full

Similar Items

Similar Items